L 152804
CAS No. 6508-43-6
L 152804 ( —— )
产品货号. M33396 CAS No. 6508-43-6
L 152804 是一种具有口服活性的、选择性的神经肽 Y Y5 受体 (NPY5-R) 拮抗剂,其对 hY5 的 Ki 值为 26 nM。L 152804 通过调节食物摄入和能量消耗,使饮食引起的肥胖小鼠体重减轻。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥425 | 有现货 |
|
| 10MG | ¥701 | 有现货 |
|
| 25MG | ¥1144 | 有现货 |
|
| 50MG | ¥1758 | 有现货 |
|
| 100MG | ¥2457 | 有现货 |
|
| 200MG | ¥3447 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥466 | 有现货 |
|
生物学信息
-
产品名称L 152804
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述L 152804 是一种具有口服活性的、选择性的神经肽 Y Y5 受体 (NPY5-R) 拮抗剂,其对 hY5 的 Ki 值为 26 nM。L 152804 通过调节食物摄入和能量消耗,使饮食引起的肥胖小鼠体重减轻。
-
产品描述L 152804 is an orally active and selective neuropeptide Y Y5 receptor (NPY5-R) antagonist, with a Ki of 26 nM for hY5. L 152804 causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure.
-
体外实验——
-
体内实验——
-
同义词——
-
通路GPCR/G Protein
-
靶点Neuropeptide Y Receptor
-
受体Neuropeptide Y Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number6508-43-6
-
分子量366.45
-
分子式C23H26O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : ≥ 125 mg/mL (341.11 mM)
-
SMILESCC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc23)C(=O)C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
CART (55-102) (human...
Cocaine- and amphetamine-regulated transcript (CART) with potent appetite-suppressing activity. Satiety factor; inhibits normal and starvation-induced feeding. Closely related to the actions of leptin and neuropeptide Y; blocks the neuropeptide Y-induced feeding response.
-
Galanin Receptor Lig...
The chimeric peptide M35 [galanin (1-13)-bradykinin(2-9) amide] is a high-affinity galanin receptor ligand acting as a galanin receptor antagonist in the rat spinal cord, rat hippocampus and isolated mouse pancreatic islets. The radiolabelled M35 and performed equilibrium binding studies with [125I] M35 on the rat pancreatic beta-cell line Rin m 5F.
-
M617
Selective galanin GAL1 receptor agonist (Ki values are 0.23 and 5.71 nM for GAL1 and GAL2 receptors respectively). Enhances food consumption in rats following i.c.v. administration and reduces CAP-induced inflammatory pain.
021-51111890
购物车()
sales@molnova.cn

